Hand osteoarthritis and the vascular treatment option most patients never hear about.

October 20 is World Osteoporosis Day – a global reminder that bone and joint health deserves attention, not acceptance. For the estimated 27 million Americans living with osteoarthritis, this message is personal.

Hand osteoarthritis is one of the most common forms of the disease. The morning stiffness. The aching that makes opening a jar or gripping a coffee mug a process. The hands that hurt before the day has even started.

Most patients with hand osteoarthritis are told to manage symptoms with anti-inflammatory medications, hot and cold therapy, and eventually splinting. Surgery is reserved for severe structural damage. What most patients are never told is that there is a minimally invasive vascular option that targets the blood vessels driving chronic pain – and it may work when everything else has not.

Read Also: Understanding Vascular and Joint Conditions | Heart Vascular and Leg Center

What Is Hand Osteoarthritis?

Osteoarthritis (OA) is the most common form of arthritis. It develops when the cartilage that cushions the ends of bones wears down over time. In the hands, OA most commonly affects the joint at the base of the thumb (CMC joint), the joints at the tips of the fingers (DIP joints), and the middle finger joints (PIP joints).

As cartilage breaks down, bones can rub against each other, causing pain, stiffness, and bony enlargements known as Heberden nodes (at DIP joints) and Bouchard nodes (at PIP joints). Range of motion decreases, and grip strength diminishes.

Who Is Affected?

Hand OA is significantly more common in women, particularly after menopause. Age is the primary risk factor – prevalence increases sharply after 50. Genetics, prior hand injuries, and occupations involving repetitive hand use also raise risk.

Osteoarthritis Prevalence – Arthritis Foundation ↗

Why Standard Treatments Often Fall Short

For most patients, hand OA management follows a predictable path: NSAIDs for inflammation, acetaminophen for pain, cortisone injections for flares, hand therapy, and splinting. These approaches can help – but they are symptom management, not source treatment.

Cortisone injections, in particular, are limited. They can provide relief for weeks to months, but repeated injections over time can damage cartilage and tendons. Their effectiveness also tends to decrease with each successive round.

The limitations of this approach leave many patients stuck in a cycle of partial relief followed by return of symptoms – with surgery as the only perceived escalation option.

Surgery Is Not Always the Answer

Joint replacement surgery for the hand is available for severe CMC joint degeneration, and fusion is used for end-stage finger joint OA. These are appropriate for the right patients. But many people with significant pain do not have damage severe enough to warrant surgery – and are left without effective options in the gap between medications and surgery.

This is exactly where vascular intervention has emerged as a meaningful option.

The Vascular Source of Chronic Joint Pain

Research in the last decade has identified that chronic musculoskeletal pain – in joints affected by osteoarthritis, tendinopathy, and chronic inflammation – is sustained in part by abnormal blood vessel growth.

The process works like this: when a joint is stressed or injured, the body sends new blood vessels to the area to deliver healing resources. In normal recovery, these vessels recede. In chronic conditions like OA, they do not. Instead, a dense network of abnormal vessels – along with accompanying nerve fibers – proliferates in the synovial membrane and surrounding tissue. These nerves continuously signal pain, even when the structural damage has not significantly changed.

This mechanism, called synovial neovascularization, has been identified in rheumatoid arthritis, knee OA, and increasingly in hand and finger joints.

Synovial Neovascularization in Osteoarthritis – National Library of Medicine ↗

TAME for Hand Osteoarthritis: How It Works

TAME – Targeted Arterial Micro-Embolization – addresses this abnormal vascular growth directly. Using a catheter guided under real-time imaging, an interventional radiologist delivers tiny embolic particles to the vessels feeding the abnormal network in the affected joint.

When blood flow to the abnormal vessels is reduced, the network recedes. The nerve fibers that accompanied it lose their sustaining signal. Pain diminishes – often significantly – without any incision, no joint resurfacing, and no implants.

Chronic Hand Pain Treatment

The Connection to GAE

Genicular artery embolization (GAE) for knee osteoarthritis uses the same principle – and has the most robust clinical evidence base for embolization in musculoskeletal pain. TAME applies the same mechanism to other joints, including the shoulder, hand, hip, and heel.

Genicular Artery Embolization for Knee Pain

GAE Clinical Evidence – Journal of Vascular and Interventional Radiology ↗

What the Research Shows

Clinical evidence for hand and finger joint embolization is earlier stage than GAE for knee, but published studies show meaningful results:

• Significant reduction in pain scores in patients with finger joint OA treated with embolization
• Improved grip strength and functional hand use reported at follow-up
• Minimal adverse effects in treated patients across published case series
• Some patients who had failed multiple cortisone injections achieved sustained relief following embolization

Embolization for Hand and Finger Joint Pain – Cardiovascular and Interventional Radiology ↗

The procedure is not appropriate for every patient with hand OA, and an evaluation is necessary to determine candidacy. But for patients who have tried conservative care without adequate relief, it represents an option that was not previously available.

Who Is a Good Candidate for TAME?

The team at Heart Vascular and Leg Center evaluates each patient individually. In general, good candidates for TAME in hand OA include:

• Patients with confirmed hand osteoarthritis on imaging (X-ray, MRI, or ultrasound)
• Pain that has persisted for three or more months despite conservative treatment
• Patients who have had limited or decreasing benefit from cortisone injections
• Patients who are not surgical candidates or who wish to avoid surgery
• Patients with inflammatory markers in the affected joint tissue on imaging

Patients with complete joint collapse or severe structural deformity may be better served by surgical options. The evaluation will clarify which approach best fits your situation.

The Procedure Experience

TAME is an outpatient procedure done under local anesthesia with light sedation. It typically takes one to two hours. Here is what the process looks like:

• Consultation and imaging review: Prior imaging is reviewed, and the treatment plan is developed. Blood work is done in advance.
• Day of procedure: A small catheter – thinner than a standard IV – is inserted through the wrist or groin. You are awake but comfortable throughout.
• Navigation and embolization: Using real-time fluoroscopy, the physician guides the catheter to the vessels supplying the affected hand joint and delivers embolic microspheres.
• Post-procedure: You rest for an hour and are then discharged. Most patients return to light daily activities the next day.
• Follow-up: Appointments at two weeks, six weeks, and three months track your progress and response.

What to Expect After TAME

Improvement is typically gradual. Most patients notice reduced stiffness and aching two to four weeks after the procedure, with more significant pain reduction by six to eight weeks. Hand therapy during this window can help rebuild strength and range of motion.

Morning stiffness – often one of the most debilitating symptoms of hand OA – is commonly reported to improve in the weeks following treatment as inflammation in the joint tissue recedes.

Talk to the team about whether TAME is right for your hand pain. Schedule a Consultation

World Osteoporosis Day 2026: Rethinking What Is Possible

World Osteoporosis Day on October 20 draws attention to bone and joint conditions that affect how people move through the world. Hand osteoarthritis is rarely life-threatening, but it is life-limiting – shrinking the ability to cook, write, work, and hold the people you love.

The message this year is not just about awareness. It is about action. If what you are currently doing for your hands is not working, there may be an option you have not considered yet.

World Osteoporosis Day – International Osteoporosis Foundation ↗

Frequently Asked Questions

Q: Is TAME for hand OA the same as surgery?

A: No. TAME is a minimally invasive catheter-based procedure with no incisions, no implants, and no general anesthesia. Surgery involves restructuring or replacing the joint; TAME targets the blood vessels driving chronic pain without altering joint anatomy.

Q: How long does it take to feel results after TAME?

A: Most patients notice improvement starting two to four weeks after the procedure. More significant pain reduction is typically seen by six to eight weeks. The full response continues to develop over the following months.

Q: Can I still try surgery later if TAME does not work?

A: Yes. TAME does not affect joint anatomy and does not preclude surgical options if needed in the future. It is often considered as an intermediate step between conservative management and surgery.

Q: Which hand joints can TAME treat?

A: TAME can be applied to the CMC joint at the base of the thumb and the PIP and DIP joints in the fingers. The evaluation determines which joints have the vascular pattern that makes them candidates for the procedure.

Q: What if my hand pain is from rheumatoid arthritis, not OA?

A: TAME is primarily studied in osteoarthritis and mechanical joint conditions. Rheumatoid arthritis involves systemic immune mechanisms that require disease-modifying medical therapy. The evaluation will help determine whether the underlying cause of your pain is suitable for TAME.

Your Next Step

Accepting morning hand pain as an inevitable part of aging is understandable – but it does not have to be permanent. A vascular evaluation can reveal whether abnormal vessel growth is sustaining your pain and whether TAME is an appropriate option.

The team at Heart Vascular and Leg Center in Bakersfield is experienced in evaluating and treating musculoskeletal pain through minimally invasive vascular approaches. The first step is a conversation.

Schedule your hand pain consultation today. Schedule a Consultation